查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1757713

全球血管内动脉瘤修復市场

Endovascular Aneurysm Repair
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 276 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

到 2030 年，全球血管内动脉瘤修復市场规模将达到 30 亿美元

全球血管内动脉瘤修復市场规模预计在2024年为25亿美元，预计到2030年将达到30亿美元，在分析期间（2024-2030年）的复合年增长率为3.3%。腹部主动脉血管瘤是本报告分析的细分市场之一，预计其复合年增长率为3.0%，到分析期结束时将达到16亿美元。胸主动脉瘤细分市场在分析期间的复合年增长率估计为3.9%。

美国市场规模估计为 6.776 亿美元，中国市场预计复合年增长率为 6.1%

预计2024年美国血管内动脉瘤修復市场规模将达6.776亿美元。作为世界第二大经济体，中国市场规模预计到2030年将达到5.968亿美元，在2024-2030年的分析期间内，复合年增长率为6.1%。其他值得关注的区域市场包括日本和加拿大，预计在分析期间内，这两个市场的复合年增长率分别为1.3%和2.5%。在欧洲，预计德国市场的复合年增长率为1.9%。

全球血管内动脉瘤修復市场—主要趋势与驱动因素摘要

为什么血管内动脉瘤修復正在重新定义血管医学中的动脉瘤治疗？

血管内动脉瘤修復 (EVAR) 为腹主动脉瘤和胸主动脉瘤的治疗带来了革命性的变化，它是一种可取代传统开放性手术的微创修復方法。该手术包括透过腹股沟的小切口插入血管支架，并透过鼠蹊部动脉将其引导至血管支架部位，在那里部署以加强薄弱的血管壁并防止破裂。与开放性手术相比，EVAR 具有许多优势，包括失血量更少、手术全期併发症更少、住院时间更短以及恢復时间更快。这对于老年患者和患有併发症而无法耐受大手术的患者尤其有利。由于人口老化、高血压、吸烟、动脉粥状硬化等原因，全球主动脉瘤发生率不断上升，大大增加了对 EVAR 等更安全、更有效干预措施的临床需求。随着血管影像和血管支架设计的不断改进，EVAR 已成为许多具有适当解剖结构的患者的首选治疗方法。此外，广泛的筛检项目和影像技术的进步使得无症状性动脉瘤的早期发现成为可能，从而扩大了EVAR的潜在治疗范围。因此，EVAR不仅改变了动脉瘤的治疗方式，也透过提供一条低风险、高回报的復健和长寿之路，重塑了患者的期望。

技术进步如何提高 EVAR 手术的准确性和结果？

在血管支架设计、影像技术和手术的不断创新的推动下，血管内动脉瘤修復领域正在迅速发展。现代血管支架设计灵活、耐用且贴合性好，可适应各种患者解剖结构，包括曲折和有角的血管。栅栏式和分叉式血管支架血管支架的应用使得能够治疗涉及或靠近主要动脉分支（如肾动脉和髂动脉）的动脉瘤，而这些病例先前被认为不适合 EVAR。即时 3D 影像引导导航系统，如融合成像和血管内超音波(IVUS)，已显着提高移植物放置的准确性，并减少了併发症和显影剂的需求。机器人辅助和导管输送系统提高了精确度和操作员控制，尤其是在复杂的主动脉解剖结构中。人们也正在研究生物可吸收材料和药物释放型支架的创新，以改善移植物整合并降低长期风险，如内漏和移植物移位。术后监测也受益于穿戴式技术和行动医疗平台的进步，这些技术和平台实现了远端追踪和併发症的早期发现。这些技术创新不仅提高了EVAR手术的安全性和有效性，也扩大了其应用范围，突破了血管内治疗的极限。

为什么 EVAR 的需求在各个人口群体和全球各个地区都在扩大？

由于临床、经济和人口统计等多种因素，不同年龄层、不同患者群体和不同地理区域对血管内动脉瘤修復的需求正在迅速增长。在高所得国家，人口老化是主要驱动因素，男性，尤其是65岁及以上男性，患有腹部主动脉血管瘤(AAA) 的风险更高。这些国家也受惠于完善的筛检计画、先进的影像技术以及专科血管中心的便利，从而能够在动脉瘤破裂前进行早期诊断和选择性血管内修復 (EVAR)。相较之下，新兴国家的糖尿病、高血压和吸烟等心血管危险因子急剧上升，加重了动脉瘤的负担。随着医疗基础设施的改善和血管内治疗可近性的提高，这些市场为EVAR技术带来了巨大的成长机会。此外，在培训、流程标准化和血管支架系统简化的推动下，EVAR的应用范围正在从三级医疗中心扩展到区域和社区医院。患者在治疗决策中也发挥更积极的作用，其中许多人更倾向于创伤性更小、恢復更快、术后疼痛更少的治疗方案。 EVAR 的仿单标示外使用已在患有结缔组织疾病和创伤性主动脉损伤的年轻患者中得到探索，并取得了令人欣喜的成果。从军事医学到灾难应变和移动外科手术单元，EVAR 的多功能性使其适用于各种医疗保健环境，进一步推动了全球需求。

推动血管内动脉瘤修復市场加速成长的因素是什么？

血管内动脉瘤修復市场的成长受到技术、临床、经济和监管等多种因素的共同驱动，这些因素共同推动着该产业的扩张和成熟。最重要的成长要素之一是主动脉瘤盛行率的不断上升，尤其是在老化人口和具有心血管风险因素的人群中。越来越多的医疗保健提供者选择血管内动脉瘤修復 (EVAR) 而非开放性手术，因为其併发症率更低、恢復时间更短且对医院资源的利用率更低。监管核准和报销政策也发挥关键作用，越来越多的 EVAR 设备被批准用于更广泛的解剖适应症，并被纳入保险覆盖范围。门诊血管外科中心和混合手术室的兴起，使得医院无需大规模基础设施建设即可实施 EVAR。此外，医生和患者对动脉瘤症状、风险因素和筛检建议的认识不断提高，也推动了早期诊断和及时介入。医疗设备製造商正在大力投资研发下一代移植物和输送系统，建构一系列有望减少手术併发症和长期併发症的创新技术。随着临床指南持续青睐微创解决方案，以及全球医疗保健系统转向预防性护理，EVAR 预计将在成熟市场和新兴市场保持持续的高成长动能。

部分

适应症（腹部主动脉血管瘤、胸主动脉瘤、其他适应症）；产品（经皮EVAR、栅栏式 EVAR、主动脉支架和 TAA 移植物、其他产品）

受访公司范例（总合36家）

  • Abbott Laboratories
  • Bolton Medical, Inc.
  • Boston Scientific Corporation
  • CR Bard（a BD company）
  • Cardinal Health, Inc.
  • Cook Medical LLC
  • Cordis Corporation（Johnson & Johnson）
  • Endologix, Inc.
  • Endospan Ltd.
  • Getinge AB
  • JOTEC GmbH
  • L. Gore & Associates, Inc.（Gore Medical）
  • Lombard Medical Limited
  • Medtronic plc
  • Philips Healthcare
  • Shanghai MicroPort Medical（Group）Co., Ltd.
  • Teleflex Incorporated
  • Terumo Corporation
  • TriVascular Technologies, Inc.
  • Volcano Corporation（a Philips company）

人工智慧集成

我们正在利用可操作的专家内容和人工智慧工具来改变市场和竞争情报。

Global 特定产业SLM 的典型规范，而是建立了一个从全球专家收集的内容库，其中包括视讯录影、部落格、搜寻引擎研究以及大量的公司、产品/服务和市场数据。

关税影响係数

全球产业分析师根据公司总部所在国家、製造地、进出口状况（成品和原始OEM）预测其竞争态势的变化。这种复杂且多面向的市场动态预计将以多种方式影响竞争对手，包括销货成本成本 (COGS) 上升、盈利下降、供应链重组以及其他微观和宏观市场动态。

目录

第一章调查方法

第二章执行摘要

  • 市场概览
  • 主要企业
  • 市场趋势和驱动因素
  • 全球市场展望

第三章市场分析

  • 美国
  • 加拿大
  • 日本
  • 中国
  • 欧洲
  • 法国
  • 德国
  • 义大利
  • 英国
  • 西班牙
  • 俄罗斯
  • 其他欧洲国家
  • 亚太地区
  • 澳洲
  • 印度
  • 韩国
  • 其他亚太地区
  • 拉丁美洲
  • 阿根廷
  • 巴西
  • 墨西哥
  • 其他拉丁美洲
  • 中东
  • 伊朗
  • 以色列
  • 沙乌地阿拉伯
  • 阿拉伯聯合大公国
  • 其他中东地区
  • 非洲

第四章 竞赛

简介目录
Product Code: MCP35014

Global Endovascular Aneurysm Repair Market to Reach US$3.0 Billion by 2030

The global market for Endovascular Aneurysm Repair estimated at US$2.5 Billion in the year 2024, is expected to reach US$3.0 Billion by 2030, growing at a CAGR of 3.3% over the analysis period 2024-2030. Abdominal Aortic Aneurysm, one of the segments analyzed in the report, is expected to record a 3.0% CAGR and reach US$1.6 Billion by the end of the analysis period. Growth in the Thoracic Aortic Aneurysm segment is estimated at 3.9% CAGR over the analysis period.

The U.S. Market is Estimated at US$677.6 Million While China is Forecast to Grow at 6.1% CAGR

The Endovascular Aneurysm Repair market in the U.S. is estimated at US$677.6 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$596.8 Million by the year 2030 trailing a CAGR of 6.1% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.3% and 2.5% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 1.9% CAGR.

Global Endovascular Aneurysm Repair Market - Key Trends & Drivers Summarized

Why Is Endovascular Aneurysm Repair Redefining Aneurysm Treatment in Vascular Medicine?

Endovascular Aneurysm Repair (EVAR) has revolutionized the management of abdominal and thoracic aortic aneurysms by providing a minimally invasive alternative to traditional open surgical repair. This technique involves inserting a stent graft through a small incision in the groin and navigating it via the femoral artery to the site of the aneurysm, where it is deployed to reinforce the weakened vessel wall and prevent rupture. EVAR offers numerous benefits over open surgery, including reduced blood loss, lower perioperative morbidity, shorter hospital stays, and faster recovery times. It is especially advantageous for elderly patients or those with comorbidities who may not tolerate major surgery. The rising global incidence of aortic aneurysms-driven by aging populations, hypertension, smoking, and atherosclerosis-has significantly increased the clinical need for safer, more efficient interventions like EVAR. As vascular imaging and stent-graft design continue to improve, EVAR has become the first-line treatment for many patients with suitable anatomy. Additionally, widespread screening programs and improved diagnostic imaging have led to earlier detection of asymptomatic aneurysms, expanding the potential candidate pool for EVAR procedures. As a result, EVAR is not only transforming how aneurysms are treated but also reshaping patient expectations by offering a lower-risk, high-reward path to recovery and longevity.

How Are Technological Innovations Enhancing the Precision and Outcomes of EVAR Procedures?

The field of endovascular aneurysm repair is advancing rapidly, fueled by continual innovations in stent graft design, imaging technologies, and procedural techniques. Modern stent grafts are now designed with greater flexibility, durability, and conformability to accommodate a wider range of patient anatomies, including those with tortuous or angulated vessels. The advent of fenestrated and branched stent grafts has made it possible to treat aneurysms that involve or are close to major arterial branches such as the renal and iliac arteries-cases that were previously deemed unsuitable for EVAR. Real-time 3D image-guided navigation systems, such as fusion imaging and intravascular ultrasound (IVUS), have dramatically improved the accuracy of graft placement, reducing complications and the need for contrast agents. Robotic-assisted and catheter-based delivery systems are enhancing precision and operator control, particularly in complex aortic anatomies. Innovations in bioresorbable materials and drug-eluting stents are also being explored to improve graft integration and reduce long-term risks such as endoleaks or graft migration. Post-procedural monitoring has benefited from advancements in wearable technology and mobile health platforms, which allow for remote follow-up and early detection of complications. Collectively, these innovations are not only improving the safety and efficacy of EVAR procedures but also expanding their applicability, pushing the boundaries of what can be achieved through endovascular intervention.

Why Is the Demand for EVAR Expanding Across Demographics and Global Regions?

The demand for endovascular aneurysm repair is expanding rapidly across age groups, patient profiles, and geographic regions due to a combination of clinical, economic, and demographic factors. In high-income countries, the aging population is a key driver, with men over 65 being particularly at risk for abdominal aortic aneurysms (AAA). These nations also benefit from established screening programs, advanced imaging capabilities, and access to specialized vascular centers, enabling early diagnosis and elective EVAR before rupture occurs. In contrast, emerging economies are seeing a surge in cardiovascular risk factors-including diabetes, hypertension, and smoking-contributing to a growing aneurysm burden. As healthcare infrastructure improves and access to endovascular procedures increases, these markets represent significant growth opportunities for EVAR technologies. Moreover, the adoption of EVAR is extending beyond tertiary care centers to regional and community hospitals, supported by advancements in training, procedural standardization, and simplified stent-graft systems. Patients are also playing a more active role in treatment decisions, with many favoring minimally invasive options that allow for quicker recovery and less postoperative pain. In younger patients with connective tissue disorders or traumatic aortic injuries, off-label use of EVAR is being explored with promising outcomes. From military medicine to disaster response and mobile surgical units, the versatility of EVAR makes it highly adaptable across diverse healthcare environments, further driving global demand.

What Factors Are Fueling the Accelerated Growth of the Endovascular Aneurysm Repair Market?

The growth in the endovascular aneurysm repair market is driven by a convergence of technological, clinical, economic, and regulatory factors that collectively point to an expanding and maturing field. One of the most significant growth drivers is the increasing prevalence of aortic aneurysms, particularly in aging populations and among individuals with cardiovascular risk factors. Healthcare providers are increasingly opting for EVAR over open surgery due to its lower complication rates, shorter recovery time, and reduced hospital resource utilization-factors that align well with value-based healthcare models and cost-containment initiatives. Regulatory approvals and reimbursement policies are also playing a crucial role, with more EVAR devices receiving clearance for broader anatomical indications and being included in insurance coverage plans. The rise of outpatient vascular surgery centers and hybrid operating rooms has made it more feasible for hospitals to adopt EVAR without major infrastructure overhauls. Additionally, increased awareness among both physicians and patients regarding aneurysm symptoms, risk factors, and screening recommendations is driving earlier diagnosis and timely intervention. Medical device companies are investing heavily in R&D to develop next-generation grafts and delivery systems, creating a pipeline of innovations that promise to reduce procedural complexity and long-term complications. As clinical guidelines continue to favor minimally invasive solutions and global healthcare systems pivot toward proactive, preventative care, EVAR is poised for sustained, high-growth momentum across both mature and emerging markets.

SCOPE OF STUDY:

The report analyzes the Endovascular Aneurysm Repair market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Indication (Abdominal Aortic Aneurysm, Thoracic Aortic Aneurysm, Other Indications); Product (Percutaneous EVAR, Fenestrated EVAR, Aortic Stents & TAA Graft, Other Products)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 36 Featured) -

  • Abbott Laboratories
  • Bolton Medical, Inc.
  • Boston Scientific Corporation
  • C.R. Bard (a BD company)
  • Cardinal Health, Inc.
  • Cook Medical LLC
  • Cordis Corporation (Johnson & Johnson)
  • Endologix, Inc.
  • Endospan Ltd.
  • Getinge AB
  • JOTEC GmbH
  • L. Gore & Associates, Inc. (Gore Medical)
  • Lombard Medical Limited
  • Medtronic plc
  • Philips Healthcare
  • Shanghai MicroPort Medical (Group) Co., Ltd.
  • Teleflex Incorporated
  • Terumo Corporation
  • TriVascular Technologies, Inc.
  • Volcano Corporation (a Philips company)

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Tariff Impact on Global Supply Chain Patterns
    • Endovascular Aneurysm Repair - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Aging Patient Population Throws the Spotlight on Minimally Invasive Aneurysm Repair Options
    • Rising Prevalence of Abdominal Aortic Aneurysms Propels Growth in Endovascular Treatment Adoption
    • Preference for Shorter Hospital Stays Expands Addressable Market for EVAR Procedures
    • Innovation in Stent Graft Design Strengthens the Business Case for Complex Aneurysm Treatment
    • Advances in Imaging and Navigation Systems Accelerate Demand for Precision-Guided Repairs
    • Surge in Outpatient Vascular Procedures Sustains Growth in Ambulatory EVAR Solutions
    • Growing Surgeon Comfort with Endovascular Techniques Spurs Wider Adoption in Community Hospitals
    • Post-EVAR Monitoring Requirements Generate Opportunities for Device-Enabled Surveillance Systems
    • Rising Use of Custom and Fenestrated Grafts Expands Treatment in Anatomically Challenging Cases
    • Technology Convergence in Robotics and Endovascular Tools Enhances Precision and Outcomes
    • High-Risk Patient Demographics Create Market for EVAR as Preferred Alternative to Open Surgery
    • Global Expansion of Vascular Surgery Infrastructure Fuels EVAR Penetration in Emerging Regions
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Endovascular Aneurysm Repair Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Endovascular Aneurysm Repair by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Endovascular Aneurysm Repair by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Endovascular Aneurysm Repair by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Abdominal Aortic Aneurysm by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Abdominal Aortic Aneurysm by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Abdominal Aortic Aneurysm by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Thoracic Aortic Aneurysm by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Thoracic Aortic Aneurysm by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Thoracic Aortic Aneurysm by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Other Indications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Other Indications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Other Indications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Percutaneous EVAR by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Percutaneous EVAR by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Percutaneous EVAR by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Fenestrated EVAR by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Fenestrated EVAR by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Fenestrated EVAR by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Aortic Stents & TAA Graft by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Aortic Stents & TAA Graft by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for Aortic Stents & TAA Graft by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Other Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Other Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 25: World 15-Year Perspective for Other Products by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Endovascular Aneurysm Repair Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 26: USA Recent Past, Current & Future Analysis for Endovascular Aneurysm Repair by Indication - Abdominal Aortic Aneurysm, Thoracic Aortic Aneurysm and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 27: USA Historic Review for Endovascular Aneurysm Repair by Indication - Abdominal Aortic Aneurysm, Thoracic Aortic Aneurysm and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 28: USA 15-Year Perspective for Endovascular Aneurysm Repair by Indication - Percentage Breakdown of Value Sales for Abdominal Aortic Aneurysm, Thoracic Aortic Aneurysm and Other Indications for the Years 2015, 2025 & 2030
    • TABLE 29: USA Recent Past, Current & Future Analysis for Endovascular Aneurysm Repair by Product - Percutaneous EVAR, Fenestrated EVAR, Aortic Stents & TAA Graft and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 30: USA Historic Review for Endovascular Aneurysm Repair by Product - Percutaneous EVAR, Fenestrated EVAR, Aortic Stents & TAA Graft and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 31: USA 15-Year Perspective for Endovascular Aneurysm Repair by Product - Percentage Breakdown of Value Sales for Percutaneous EVAR, Fenestrated EVAR, Aortic Stents & TAA Graft and Other Products for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 32: Canada Recent Past, Current & Future Analysis for Endovascular Aneurysm Repair by Indication - Abdominal Aortic Aneurysm, Thoracic Aortic Aneurysm and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Canada Historic Review for Endovascular Aneurysm Repair by Indication - Abdominal Aortic Aneurysm, Thoracic Aortic Aneurysm and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 34: Canada 15-Year Perspective for Endovascular Aneurysm Repair by Indication - Percentage Breakdown of Value Sales for Abdominal Aortic Aneurysm, Thoracic Aortic Aneurysm and Other Indications for the Years 2015, 2025 & 2030
    • TABLE 35: Canada Recent Past, Current & Future Analysis for Endovascular Aneurysm Repair by Product - Percutaneous EVAR, Fenestrated EVAR, Aortic Stents & TAA Graft and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 36: Canada Historic Review for Endovascular Aneurysm Repair by Product - Percutaneous EVAR, Fenestrated EVAR, Aortic Stents & TAA Graft and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 37: Canada 15-Year Perspective for Endovascular Aneurysm Repair by Product - Percentage Breakdown of Value Sales for Percutaneous EVAR, Fenestrated EVAR, Aortic Stents & TAA Graft and Other Products for the Years 2015, 2025 & 2030
  • JAPAN
    • Endovascular Aneurysm Repair Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 38: Japan Recent Past, Current & Future Analysis for Endovascular Aneurysm Repair by Indication - Abdominal Aortic Aneurysm, Thoracic Aortic Aneurysm and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Japan Historic Review for Endovascular Aneurysm Repair by Indication - Abdominal Aortic Aneurysm, Thoracic Aortic Aneurysm and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 40: Japan 15-Year Perspective for Endovascular Aneurysm Repair by Indication - Percentage Breakdown of Value Sales for Abdominal Aortic Aneurysm, Thoracic Aortic Aneurysm and Other Indications for the Years 2015, 2025 & 2030
    • TABLE 41: Japan Recent Past, Current & Future Analysis for Endovascular Aneurysm Repair by Product - Percutaneous EVAR, Fenestrated EVAR, Aortic Stents & TAA Graft and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 42: Japan Historic Review for Endovascular Aneurysm Repair by Product - Percutaneous EVAR, Fenestrated EVAR, Aortic Stents & TAA Graft and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 43: Japan 15-Year Perspective for Endovascular Aneurysm Repair by Product - Percentage Breakdown of Value Sales for Percutaneous EVAR, Fenestrated EVAR, Aortic Stents & TAA Graft and Other Products for the Years 2015, 2025 & 2030
  • CHINA
    • Endovascular Aneurysm Repair Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 44: China Recent Past, Current & Future Analysis for Endovascular Aneurysm Repair by Indication - Abdominal Aortic Aneurysm, Thoracic Aortic Aneurysm and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 45: China Historic Review for Endovascular Aneurysm Repair by Indication - Abdominal Aortic Aneurysm, Thoracic Aortic Aneurysm and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 46: China 15-Year Perspective for Endovascular Aneurysm Repair by Indication - Percentage Breakdown of Value Sales for Abdominal Aortic Aneurysm, Thoracic Aortic Aneurysm and Other Indications for the Years 2015, 2025 & 2030
    • TABLE 47: China Recent Past, Current & Future Analysis for Endovascular Aneurysm Repair by Product - Percutaneous EVAR, Fenestrated EVAR, Aortic Stents & TAA Graft and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 48: China Historic Review for Endovascular Aneurysm Repair by Product - Percutaneous EVAR, Fenestrated EVAR, Aortic Stents & TAA Graft and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 49: China 15-Year Perspective for Endovascular Aneurysm Repair by Product - Percentage Breakdown of Value Sales for Percutaneous EVAR, Fenestrated EVAR, Aortic Stents & TAA Graft and Other Products for the Years 2015, 2025 & 2030
  • EUROPE
    • Endovascular Aneurysm Repair Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Endovascular Aneurysm Repair by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 51: Europe Historic Review for Endovascular Aneurysm Repair by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 52: Europe 15-Year Perspective for Endovascular Aneurysm Repair by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 53: Europe Recent Past, Current & Future Analysis for Endovascular Aneurysm Repair by Indication - Abdominal Aortic Aneurysm, Thoracic Aortic Aneurysm and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Europe Historic Review for Endovascular Aneurysm Repair by Indication - Abdominal Aortic Aneurysm, Thoracic Aortic Aneurysm and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 55: Europe 15-Year Perspective for Endovascular Aneurysm Repair by Indication - Percentage Breakdown of Value Sales for Abdominal Aortic Aneurysm, Thoracic Aortic Aneurysm and Other Indications for the Years 2015, 2025 & 2030
    • TABLE 56: Europe Recent Past, Current & Future Analysis for Endovascular Aneurysm Repair by Product - Percutaneous EVAR, Fenestrated EVAR, Aortic Stents & TAA Graft and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Europe Historic Review for Endovascular Aneurysm Repair by Product - Percutaneous EVAR, Fenestrated EVAR, Aortic Stents & TAA Graft and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 58: Europe 15-Year Perspective for Endovascular Aneurysm Repair by Product - Percentage Breakdown of Value Sales for Percutaneous EVAR, Fenestrated EVAR, Aortic Stents & TAA Graft and Other Products for the Years 2015, 2025 & 2030
  • FRANCE
    • Endovascular Aneurysm Repair Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 59: France Recent Past, Current & Future Analysis for Endovascular Aneurysm Repair by Indication - Abdominal Aortic Aneurysm, Thoracic Aortic Aneurysm and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 60: France Historic Review for Endovascular Aneurysm Repair by Indication - Abdominal Aortic Aneurysm, Thoracic Aortic Aneurysm and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 61: France 15-Year Perspective for Endovascular Aneurysm Repair by Indication - Percentage Breakdown of Value Sales for Abdominal Aortic Aneurysm, Thoracic Aortic Aneurysm and Other Indications for the Years 2015, 2025 & 2030
    • TABLE 62: France Recent Past, Current & Future Analysis for Endovascular Aneurysm Repair by Product - Percutaneous EVAR, Fenestrated EVAR, Aortic Stents & TAA Graft and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: France Historic Review for Endovascular Aneurysm Repair by Product - Percutaneous EVAR, Fenestrated EVAR, Aortic Stents & TAA Graft and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 64: France 15-Year Perspective for Endovascular Aneurysm Repair by Product - Percentage Breakdown of Value Sales for Percutaneous EVAR, Fenestrated EVAR, Aortic Stents & TAA Graft and Other Products for the Years 2015, 2025 & 2030
  • GERMANY
    • Endovascular Aneurysm Repair Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 65: Germany Recent Past, Current & Future Analysis for Endovascular Aneurysm Repair by Indication - Abdominal Aortic Aneurysm, Thoracic Aortic Aneurysm and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Germany Historic Review for Endovascular Aneurysm Repair by Indication - Abdominal Aortic Aneurysm, Thoracic Aortic Aneurysm and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 67: Germany 15-Year Perspective for Endovascular Aneurysm Repair by Indication - Percentage Breakdown of Value Sales for Abdominal Aortic Aneurysm, Thoracic Aortic Aneurysm and Other Indications for the Years 2015, 2025 & 2030
    • TABLE 68: Germany Recent Past, Current & Future Analysis for Endovascular Aneurysm Repair by Product - Percutaneous EVAR, Fenestrated EVAR, Aortic Stents & TAA Graft and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Germany Historic Review for Endovascular Aneurysm Repair by Product - Percutaneous EVAR, Fenestrated EVAR, Aortic Stents & TAA Graft and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 70: Germany 15-Year Perspective for Endovascular Aneurysm Repair by Product - Percentage Breakdown of Value Sales for Percutaneous EVAR, Fenestrated EVAR, Aortic Stents & TAA Graft and Other Products for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 71: Italy Recent Past, Current & Future Analysis for Endovascular Aneurysm Repair by Indication - Abdominal Aortic Aneurysm, Thoracic Aortic Aneurysm and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Italy Historic Review for Endovascular Aneurysm Repair by Indication - Abdominal Aortic Aneurysm, Thoracic Aortic Aneurysm and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 73: Italy 15-Year Perspective for Endovascular Aneurysm Repair by Indication - Percentage Breakdown of Value Sales for Abdominal Aortic Aneurysm, Thoracic Aortic Aneurysm and Other Indications for the Years 2015, 2025 & 2030
    • TABLE 74: Italy Recent Past, Current & Future Analysis for Endovascular Aneurysm Repair by Product - Percutaneous EVAR, Fenestrated EVAR, Aortic Stents & TAA Graft and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Italy Historic Review for Endovascular Aneurysm Repair by Product - Percutaneous EVAR, Fenestrated EVAR, Aortic Stents & TAA Graft and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 76: Italy 15-Year Perspective for Endovascular Aneurysm Repair by Product - Percentage Breakdown of Value Sales for Percutaneous EVAR, Fenestrated EVAR, Aortic Stents & TAA Graft and Other Products for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Endovascular Aneurysm Repair Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 77: UK Recent Past, Current & Future Analysis for Endovascular Aneurysm Repair by Indication - Abdominal Aortic Aneurysm, Thoracic Aortic Aneurysm and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 78: UK Historic Review for Endovascular Aneurysm Repair by Indication - Abdominal Aortic Aneurysm, Thoracic Aortic Aneurysm and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 79: UK 15-Year Perspective for Endovascular Aneurysm Repair by Indication - Percentage Breakdown of Value Sales for Abdominal Aortic Aneurysm, Thoracic Aortic Aneurysm and Other Indications for the Years 2015, 2025 & 2030
    • TABLE 80: UK Recent Past, Current & Future Analysis for Endovascular Aneurysm Repair by Product - Percutaneous EVAR, Fenestrated EVAR, Aortic Stents & TAA Graft and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: UK Historic Review for Endovascular Aneurysm Repair by Product - Percutaneous EVAR, Fenestrated EVAR, Aortic Stents & TAA Graft and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 82: UK 15-Year Perspective for Endovascular Aneurysm Repair by Product - Percentage Breakdown of Value Sales for Percutaneous EVAR, Fenestrated EVAR, Aortic Stents & TAA Graft and Other Products for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 83: Spain Recent Past, Current & Future Analysis for Endovascular Aneurysm Repair by Indication - Abdominal Aortic Aneurysm, Thoracic Aortic Aneurysm and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Spain Historic Review for Endovascular Aneurysm Repair by Indication - Abdominal Aortic Aneurysm, Thoracic Aortic Aneurysm and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 85: Spain 15-Year Perspective for Endovascular Aneurysm Repair by Indication - Percentage Breakdown of Value Sales for Abdominal Aortic Aneurysm, Thoracic Aortic Aneurysm and Other Indications for the Years 2015, 2025 & 2030
    • TABLE 86: Spain Recent Past, Current & Future Analysis for Endovascular Aneurysm Repair by Product - Percutaneous EVAR, Fenestrated EVAR, Aortic Stents & TAA Graft and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Spain Historic Review for Endovascular Aneurysm Repair by Product - Percutaneous EVAR, Fenestrated EVAR, Aortic Stents & TAA Graft and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 88: Spain 15-Year Perspective for Endovascular Aneurysm Repair by Product - Percentage Breakdown of Value Sales for Percutaneous EVAR, Fenestrated EVAR, Aortic Stents & TAA Graft and Other Products for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 89: Russia Recent Past, Current & Future Analysis for Endovascular Aneurysm Repair by Indication - Abdominal Aortic Aneurysm, Thoracic Aortic Aneurysm and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Russia Historic Review for Endovascular Aneurysm Repair by Indication - Abdominal Aortic Aneurysm, Thoracic Aortic Aneurysm and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 91: Russia 15-Year Perspective for Endovascular Aneurysm Repair by Indication - Percentage Breakdown of Value Sales for Abdominal Aortic Aneurysm, Thoracic Aortic Aneurysm and Other Indications for the Years 2015, 2025 & 2030
    • TABLE 92: Russia Recent Past, Current & Future Analysis for Endovascular Aneurysm Repair by Product - Percutaneous EVAR, Fenestrated EVAR, Aortic Stents & TAA Graft and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Russia Historic Review for Endovascular Aneurysm Repair by Product - Percutaneous EVAR, Fenestrated EVAR, Aortic Stents & TAA Graft and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 94: Russia 15-Year Perspective for Endovascular Aneurysm Repair by Product - Percentage Breakdown of Value Sales for Percutaneous EVAR, Fenestrated EVAR, Aortic Stents & TAA Graft and Other Products for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 95: Rest of Europe Recent Past, Current & Future Analysis for Endovascular Aneurysm Repair by Indication - Abdominal Aortic Aneurysm, Thoracic Aortic Aneurysm and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Rest of Europe Historic Review for Endovascular Aneurysm Repair by Indication - Abdominal Aortic Aneurysm, Thoracic Aortic Aneurysm and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 97: Rest of Europe 15-Year Perspective for Endovascular Aneurysm Repair by Indication - Percentage Breakdown of Value Sales for Abdominal Aortic Aneurysm, Thoracic Aortic Aneurysm and Other Indications for the Years 2015, 2025 & 2030
    • TABLE 98: Rest of Europe Recent Past, Current & Future Analysis for Endovascular Aneurysm Repair by Product - Percutaneous EVAR, Fenestrated EVAR, Aortic Stents & TAA Graft and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Rest of Europe Historic Review for Endovascular Aneurysm Repair by Product - Percutaneous EVAR, Fenestrated EVAR, Aortic Stents & TAA Graft and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 100: Rest of Europe 15-Year Perspective for Endovascular Aneurysm Repair by Product - Percentage Breakdown of Value Sales for Percutaneous EVAR, Fenestrated EVAR, Aortic Stents & TAA Graft and Other Products for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Endovascular Aneurysm Repair Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for Endovascular Aneurysm Repair by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 102: Asia-Pacific Historic Review for Endovascular Aneurysm Repair by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 103: Asia-Pacific 15-Year Perspective for Endovascular Aneurysm Repair by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 104: Asia-Pacific Recent Past, Current & Future Analysis for Endovascular Aneurysm Repair by Indication - Abdominal Aortic Aneurysm, Thoracic Aortic Aneurysm and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Asia-Pacific Historic Review for Endovascular Aneurysm Repair by Indication - Abdominal Aortic Aneurysm, Thoracic Aortic Aneurysm and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 106: Asia-Pacific 15-Year Perspective for Endovascular Aneurysm Repair by Indication - Percentage Breakdown of Value Sales for Abdominal Aortic Aneurysm, Thoracic Aortic Aneurysm and Other Indications for the Years 2015, 2025 & 2030
    • TABLE 107: Asia-Pacific Recent Past, Current & Future Analysis for Endovascular Aneurysm Repair by Product - Percutaneous EVAR, Fenestrated EVAR, Aortic Stents & TAA Graft and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Asia-Pacific Historic Review for Endovascular Aneurysm Repair by Product - Percutaneous EVAR, Fenestrated EVAR, Aortic Stents & TAA Graft and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 109: Asia-Pacific 15-Year Perspective for Endovascular Aneurysm Repair by Product - Percentage Breakdown of Value Sales for Percutaneous EVAR, Fenestrated EVAR, Aortic Stents & TAA Graft and Other Products for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Endovascular Aneurysm Repair Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 110: Australia Recent Past, Current & Future Analysis for Endovascular Aneurysm Repair by Indication - Abdominal Aortic Aneurysm, Thoracic Aortic Aneurysm and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Australia Historic Review for Endovascular Aneurysm Repair by Indication - Abdominal Aortic Aneurysm, Thoracic Aortic Aneurysm and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 112: Australia 15-Year Perspective for Endovascular Aneurysm Repair by Indication - Percentage Breakdown of Value Sales for Abdominal Aortic Aneurysm, Thoracic Aortic Aneurysm and Other Indications for the Years 2015, 2025 & 2030
    • TABLE 113: Australia Recent Past, Current & Future Analysis for Endovascular Aneurysm Repair by Product - Percutaneous EVAR, Fenestrated EVAR, Aortic Stents & TAA Graft and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 114: Australia Historic Review for Endovascular Aneurysm Repair by Product - Percutaneous EVAR, Fenestrated EVAR, Aortic Stents & TAA Graft and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 115: Australia 15-Year Perspective for Endovascular Aneurysm Repair by Product - Percentage Breakdown of Value Sales for Percutaneous EVAR, Fenestrated EVAR, Aortic Stents & TAA Graft and Other Products for the Years 2015, 2025 & 2030
  • INDIA
    • Endovascular Aneurysm Repair Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 116: India Recent Past, Current & Future Analysis for Endovascular Aneurysm Repair by Indication - Abdominal Aortic Aneurysm, Thoracic Aortic Aneurysm and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 117: India Historic Review for Endovascular Aneurysm Repair by Indication - Abdominal Aortic Aneurysm, Thoracic Aortic Aneurysm and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 118: India 15-Year Perspective for Endovascular Aneurysm Repair by Indication - Percentage Breakdown of Value Sales for Abdominal Aortic Aneurysm, Thoracic Aortic Aneurysm and Other Indications for the Years 2015, 2025 & 2030
    • TABLE 119: India Recent Past, Current & Future Analysis for Endovascular Aneurysm Repair by Product - Percutaneous EVAR, Fenestrated EVAR, Aortic Stents & TAA Graft and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 120: India Historic Review for Endovascular Aneurysm Repair by Product - Percutaneous EVAR, Fenestrated EVAR, Aortic Stents & TAA Graft and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 121: India 15-Year Perspective for Endovascular Aneurysm Repair by Product - Percentage Breakdown of Value Sales for Percutaneous EVAR, Fenestrated EVAR, Aortic Stents & TAA Graft and Other Products for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 122: South Korea Recent Past, Current & Future Analysis for Endovascular Aneurysm Repair by Indication - Abdominal Aortic Aneurysm, Thoracic Aortic Aneurysm and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 123: South Korea Historic Review for Endovascular Aneurysm Repair by Indication - Abdominal Aortic Aneurysm, Thoracic Aortic Aneurysm and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 124: South Korea 15-Year Perspective for Endovascular Aneurysm Repair by Indication - Percentage Breakdown of Value Sales for Abdominal Aortic Aneurysm, Thoracic Aortic Aneurysm and Other Indications for the Years 2015, 2025 & 2030
    • TABLE 125: South Korea Recent Past, Current & Future Analysis for Endovascular Aneurysm Repair by Product - Percutaneous EVAR, Fenestrated EVAR, Aortic Stents & TAA Graft and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 126: South Korea Historic Review for Endovascular Aneurysm Repair by Product - Percutaneous EVAR, Fenestrated EVAR, Aortic Stents & TAA Graft and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 127: South Korea 15-Year Perspective for Endovascular Aneurysm Repair by Product - Percentage Breakdown of Value Sales for Percutaneous EVAR, Fenestrated EVAR, Aortic Stents & TAA Graft and Other Products for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 128: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Endovascular Aneurysm Repair by Indication - Abdominal Aortic Aneurysm, Thoracic Aortic Aneurysm and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Rest of Asia-Pacific Historic Review for Endovascular Aneurysm Repair by Indication - Abdominal Aortic Aneurysm, Thoracic Aortic Aneurysm and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 130: Rest of Asia-Pacific 15-Year Perspective for Endovascular Aneurysm Repair by Indication - Percentage Breakdown of Value Sales for Abdominal Aortic Aneurysm, Thoracic Aortic Aneurysm and Other Indications for the Years 2015, 2025 & 2030
    • TABLE 131: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Endovascular Aneurysm Repair by Product - Percutaneous EVAR, Fenestrated EVAR, Aortic Stents & TAA Graft and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Rest of Asia-Pacific Historic Review for Endovascular Aneurysm Repair by Product - Percutaneous EVAR, Fenestrated EVAR, Aortic Stents & TAA Graft and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 133: Rest of Asia-Pacific 15-Year Perspective for Endovascular Aneurysm Repair by Product - Percentage Breakdown of Value Sales for Percutaneous EVAR, Fenestrated EVAR, Aortic Stents & TAA Graft and Other Products for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Endovascular Aneurysm Repair Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 134: Latin America Recent Past, Current & Future Analysis for Endovascular Aneurysm Repair by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 135: Latin America Historic Review for Endovascular Aneurysm Repair by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 136: Latin America 15-Year Perspective for Endovascular Aneurysm Repair by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 137: Latin America Recent Past, Current & Future Analysis for Endovascular Aneurysm Repair by Indication - Abdominal Aortic Aneurysm, Thoracic Aortic Aneurysm and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Latin America Historic Review for Endovascular Aneurysm Repair by Indication - Abdominal Aortic Aneurysm, Thoracic Aortic Aneurysm and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 139: Latin America 15-Year Perspective for Endovascular Aneurysm Repair by Indication - Percentage Breakdown of Value Sales for Abdominal Aortic Aneurysm, Thoracic Aortic Aneurysm and Other Indications for the Years 2015, 2025 & 2030
    • TABLE 140: Latin America Recent Past, Current & Future Analysis for Endovascular Aneurysm Repair by Product - Percutaneous EVAR, Fenestrated EVAR, Aortic Stents & TAA Graft and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Latin America Historic Review for Endovascular Aneurysm Repair by Product - Percutaneous EVAR, Fenestrated EVAR, Aortic Stents & TAA Graft and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 142: Latin America 15-Year Perspective for Endovascular Aneurysm Repair by Product - Percentage Breakdown of Value Sales for Percutaneous EVAR, Fenestrated EVAR, Aortic Stents & TAA Graft and Other Products for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 143: Argentina Recent Past, Current & Future Analysis for Endovascular Aneurysm Repair by Indication - Abdominal Aortic Aneurysm, Thoracic Aortic Aneurysm and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Argentina Historic Review for Endovascular Aneurysm Repair by Indication - Abdominal Aortic Aneurysm, Thoracic Aortic Aneurysm and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 145: Argentina 15-Year Perspective for Endovascular Aneurysm Repair by Indication - Percentage Breakdown of Value Sales for Abdominal Aortic Aneurysm, Thoracic Aortic Aneurysm and Other Indications for the Years 2015, 2025 & 2030
    • TABLE 146: Argentina Recent Past, Current & Future Analysis for Endovascular Aneurysm Repair by Product - Percutaneous EVAR, Fenestrated EVAR, Aortic Stents & TAA Graft and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Argentina Historic Review for Endovascular Aneurysm Repair by Product - Percutaneous EVAR, Fenestrated EVAR, Aortic Stents & TAA Graft and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 148: Argentina 15-Year Perspective for Endovascular Aneurysm Repair by Product - Percentage Breakdown of Value Sales for Percutaneous EVAR, Fenestrated EVAR, Aortic Stents & TAA Graft and Other Products for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 149: Brazil Recent Past, Current & Future Analysis for Endovascular Aneurysm Repair by Indication - Abdominal Aortic Aneurysm, Thoracic Aortic Aneurysm and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Brazil Historic Review for Endovascular Aneurysm Repair by Indication - Abdominal Aortic Aneurysm, Thoracic Aortic Aneurysm and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 151: Brazil 15-Year Perspective for Endovascular Aneurysm Repair by Indication - Percentage Breakdown of Value Sales for Abdominal Aortic Aneurysm, Thoracic Aortic Aneurysm and Other Indications for the Years 2015, 2025 & 2030
    • TABLE 152: Brazil Recent Past, Current & Future Analysis for Endovascular Aneurysm Repair by Product - Percutaneous EVAR, Fenestrated EVAR, Aortic Stents & TAA Graft and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Brazil Historic Review for Endovascular Aneurysm Repair by Product - Percutaneous EVAR, Fenestrated EVAR, Aortic Stents & TAA Graft and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 154: Brazil 15-Year Perspective for Endovascular Aneurysm Repair by Product - Percentage Breakdown of Value Sales for Percutaneous EVAR, Fenestrated EVAR, Aortic Stents & TAA Graft and Other Products for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 155: Mexico Recent Past, Current & Future Analysis for Endovascular Aneurysm Repair by Indication - Abdominal Aortic Aneurysm, Thoracic Aortic Aneurysm and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Mexico Historic Review for Endovascular Aneurysm Repair by Indication - Abdominal Aortic Aneurysm, Thoracic Aortic Aneurysm and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 157: Mexico 15-Year Perspective for Endovascular Aneurysm Repair by Indication - Percentage Breakdown of Value Sales for Abdominal Aortic Aneurysm, Thoracic Aortic Aneurysm and Other Indications for the Years 2015, 2025 & 2030
    • TABLE 158: Mexico Recent Past, Current & Future Analysis for Endovascular Aneurysm Repair by Product - Percutaneous EVAR, Fenestrated EVAR, Aortic Stents & TAA Graft and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Mexico Historic Review for Endovascular Aneurysm Repair by Product - Percutaneous EVAR, Fenestrated EVAR, Aortic Stents & TAA Graft and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 160: Mexico 15-Year Perspective for Endovascular Aneurysm Repair by Product - Percentage Breakdown of Value Sales for Percutaneous EVAR, Fenestrated EVAR, Aortic Stents & TAA Graft and Other Products for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 161: Rest of Latin America Recent Past, Current & Future Analysis for Endovascular Aneurysm Repair by Indication - Abdominal Aortic Aneurysm, Thoracic Aortic Aneurysm and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Rest of Latin America Historic Review for Endovascular Aneurysm Repair by Indication - Abdominal Aortic Aneurysm, Thoracic Aortic Aneurysm and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 163: Rest of Latin America 15-Year Perspective for Endovascular Aneurysm Repair by Indication - Percentage Breakdown of Value Sales for Abdominal Aortic Aneurysm, Thoracic Aortic Aneurysm and Other Indications for the Years 2015, 2025 & 2030
    • TABLE 164: Rest of Latin America Recent Past, Current & Future Analysis for Endovascular Aneurysm Repair by Product - Percutaneous EVAR, Fenestrated EVAR, Aortic Stents & TAA Graft and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Rest of Latin America Historic Review for Endovascular Aneurysm Repair by Product - Percutaneous EVAR, Fenestrated EVAR, Aortic Stents & TAA Graft and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 166: Rest of Latin America 15-Year Perspective for Endovascular Aneurysm Repair by Product - Percentage Breakdown of Value Sales for Percutaneous EVAR, Fenestrated EVAR, Aortic Stents & TAA Graft and Other Products for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Endovascular Aneurysm Repair Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 167: Middle East Recent Past, Current & Future Analysis for Endovascular Aneurysm Repair by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 168: Middle East Historic Review for Endovascular Aneurysm Repair by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 169: Middle East 15-Year Perspective for Endovascular Aneurysm Repair by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 170: Middle East Recent Past, Current & Future Analysis for Endovascular Aneurysm Repair by Indication - Abdominal Aortic Aneurysm, Thoracic Aortic Aneurysm and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 171: Middle East Historic Review for Endovascular Aneurysm Repair by Indication - Abdominal Aortic Aneurysm, Thoracic Aortic Aneurysm and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 172: Middle East 15-Year Perspective for Endovascular Aneurysm Repair by Indication - Percentage Breakdown of Value Sales for Abdominal Aortic Aneurysm, Thoracic Aortic Aneurysm and Other Indications for the Years 2015, 2025 & 2030
    • TABLE 173: Middle East Recent Past, Current & Future Analysis for Endovascular Aneurysm Repair by Product - Percutaneous EVAR, Fenestrated EVAR, Aortic Stents & TAA Graft and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 174: Middle East Historic Review for Endovascular Aneurysm Repair by Product - Percutaneous EVAR, Fenestrated EVAR, Aortic Stents & TAA Graft and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 175: Middle East 15-Year Perspective for Endovascular Aneurysm Repair by Product - Percentage Breakdown of Value Sales for Percutaneous EVAR, Fenestrated EVAR, Aortic Stents & TAA Graft and Other Products for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 176: Iran Recent Past, Current & Future Analysis for Endovascular Aneurysm Repair by Indication - Abdominal Aortic Aneurysm, Thoracic Aortic Aneurysm and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Iran Historic Review for Endovascular Aneurysm Repair by Indication - Abdominal Aortic Aneurysm, Thoracic Aortic Aneurysm and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 178: Iran 15-Year Perspective for Endovascular Aneurysm Repair by Indication - Percentage Breakdown of Value Sales for Abdominal Aortic Aneurysm, Thoracic Aortic Aneurysm and Other Indications for the Years 2015, 2025 & 2030
    • TABLE 179: Iran Recent Past, Current & Future Analysis for Endovascular Aneurysm Repair by Product - Percutaneous EVAR, Fenestrated EVAR, Aortic Stents & TAA Graft and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Iran Historic Review for Endovascular Aneurysm Repair by Product - Percutaneous EVAR, Fenestrated EVAR, Aortic Stents & TAA Graft and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 181: Iran 15-Year Perspective for Endovascular Aneurysm Repair by Product - Percentage Breakdown of Value Sales for Percutaneous EVAR, Fenestrated EVAR, Aortic Stents & TAA Graft and Other Products for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 182: Israel Recent Past, Current & Future Analysis for Endovascular Aneurysm Repair by Indication - Abdominal Aortic Aneurysm, Thoracic Aortic Aneurysm and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Israel Historic Review for Endovascular Aneurysm Repair by Indication - Abdominal Aortic Aneurysm, Thoracic Aortic Aneurysm and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 184: Israel 15-Year Perspective for Endovascular Aneurysm Repair by Indication - Percentage Breakdown of Value Sales for Abdominal Aortic Aneurysm, Thoracic Aortic Aneurysm and Other Indications for the Years 2015, 2025 & 2030
    • TABLE 185: Israel Recent Past, Current & Future Analysis for Endovascular Aneurysm Repair by Product - Percutaneous EVAR, Fenestrated EVAR, Aortic Stents & TAA Graft and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Israel Historic Review for Endovascular Aneurysm Repair by Product - Percutaneous EVAR, Fenestrated EVAR, Aortic Stents & TAA Graft and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 187: Israel 15-Year Perspective for Endovascular Aneurysm Repair by Product - Percentage Breakdown of Value Sales for Percutaneous EVAR, Fenestrated EVAR, Aortic Stents & TAA Graft and Other Products for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 188: Saudi Arabia Recent Past, Current & Future Analysis for Endovascular Aneurysm Repair by Indication - Abdominal Aortic Aneurysm, Thoracic Aortic Aneurysm and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Saudi Arabia Historic Review for Endovascular Aneurysm Repair by Indication - Abdominal Aortic Aneurysm, Thoracic Aortic Aneurysm and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 190: Saudi Arabia 15-Year Perspective for Endovascular Aneurysm Repair by Indication - Percentage Breakdown of Value Sales for Abdominal Aortic Aneurysm, Thoracic Aortic Aneurysm and Other Indications for the Years 2015, 2025 & 2030
    • TABLE 191: Saudi Arabia Recent Past, Current & Future Analysis for Endovascular Aneurysm Repair by Product - Percutaneous EVAR, Fenestrated EVAR, Aortic Stents & TAA Graft and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 192: Saudi Arabia Historic Review for Endovascular Aneurysm Repair by Product - Percutaneous EVAR, Fenestrated EVAR, Aortic Stents & TAA Graft and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 193: Saudi Arabia 15-Year Perspective for Endovascular Aneurysm Repair by Product - Percentage Breakdown of Value Sales for Percutaneous EVAR, Fenestrated EVAR, Aortic Stents & TAA Graft and Other Products for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 194: UAE Recent Past, Current & Future Analysis for Endovascular Aneurysm Repair by Indication - Abdominal Aortic Aneurysm, Thoracic Aortic Aneurysm and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 195: UAE Historic Review for Endovascular Aneurysm Repair by Indication - Abdominal Aortic Aneurysm, Thoracic Aortic Aneurysm and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 196: UAE 15-Year Perspective for Endovascular Aneurysm Repair by Indication - Percentage Breakdown of Value Sales for Abdominal Aortic Aneurysm, Thoracic Aortic Aneurysm and Other Indications for the Years 2015, 2025 & 2030
    • TABLE 197: UAE Recent Past, Current & Future Analysis for Endovascular Aneurysm Repair by Product - Percutaneous EVAR, Fenestrated EVAR, Aortic Stents & TAA Graft and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 198: UAE Historic Review for Endovascular Aneurysm Repair by Product - Percutaneous EVAR, Fenestrated EVAR, Aortic Stents & TAA Graft and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 199: UAE 15-Year Perspective for Endovascular Aneurysm Repair by Product - Percentage Breakdown of Value Sales for Percutaneous EVAR, Fenestrated EVAR, Aortic Stents & TAA Graft and Other Products for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 200: Rest of Middle East Recent Past, Current & Future Analysis for Endovascular Aneurysm Repair by Indication - Abdominal Aortic Aneurysm, Thoracic Aortic Aneurysm and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Rest of Middle East Historic Review for Endovascular Aneurysm Repair by Indication - Abdominal Aortic Aneurysm, Thoracic Aortic Aneurysm and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 202: Rest of Middle East 15-Year Perspective for Endovascular Aneurysm Repair by Indication - Percentage Breakdown of Value Sales for Abdominal Aortic Aneurysm, Thoracic Aortic Aneurysm and Other Indications for the Years 2015, 2025 & 2030
    • TABLE 203: Rest of Middle East Recent Past, Current & Future Analysis for Endovascular Aneurysm Repair by Product - Percutaneous EVAR, Fenestrated EVAR, Aortic Stents & TAA Graft and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Rest of Middle East Historic Review for Endovascular Aneurysm Repair by Product - Percutaneous EVAR, Fenestrated EVAR, Aortic Stents & TAA Graft and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 205: Rest of Middle East 15-Year Perspective for Endovascular Aneurysm Repair by Product - Percentage Breakdown of Value Sales for Percutaneous EVAR, Fenestrated EVAR, Aortic Stents & TAA Graft and Other Products for the Years 2015, 2025 & 2030
  • AFRICA
    • Endovascular Aneurysm Repair Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 206: Africa Recent Past, Current & Future Analysis for Endovascular Aneurysm Repair by Indication - Abdominal Aortic Aneurysm, Thoracic Aortic Aneurysm and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Africa Historic Review for Endovascular Aneurysm Repair by Indication - Abdominal Aortic Aneurysm, Thoracic Aortic Aneurysm and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 208: Africa 15-Year Perspective for Endovascular Aneurysm Repair by Indication - Percentage Breakdown of Value Sales for Abdominal Aortic Aneurysm, Thoracic Aortic Aneurysm and Other Indications for the Years 2015, 2025 & 2030
    • TABLE 209: Africa Recent Past, Current & Future Analysis for Endovascular Aneurysm Repair by Product - Percutaneous EVAR, Fenestrated EVAR, Aortic Stents & TAA Graft and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 210: Africa Historic Review for Endovascular Aneurysm Repair by Product - Percutaneous EVAR, Fenestrated EVAR, Aortic Stents & TAA Graft and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 211: Africa 15-Year Perspective for Endovascular Aneurysm Repair by Product - Percentage Breakdown of Value Sales for Percutaneous EVAR, Fenestrated EVAR, Aortic Stents & TAA Graft and Other Products for the Years 2015, 2025 & 2030

IV. COMPETITION